STRYVE FOODS INC-CLASS A (SNAX)

US8636852027 - Common Stock

1.465  -0.03 (-2.33%)

Fundamental Rating

1

Taking everything into account, SNAX scores 1 out of 10 in our fundamental rating. SNAX was compared to 92 industry peers in the Food Products industry. Both the profitability and financial health of SNAX have multiple concerns. While showing a medium growth rate, SNAX is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

SNAX had negative earnings in the past year.
In the past year SNAX has reported a negative cash flow from operations.
SNAX had negative earnings in each of the past 5 years.
In the past 5 years SNAX always reported negative operating cash flow.

1.2 Ratios

SNAX has a Return On Assets of -51.50%. This is amonst the worse of the industry: SNAX underperforms 85.71% of its industry peers.
With a Return On Equity value of -317.88%, SNAX is not doing good in the industry: 89.01% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -51.5%
ROE -317.88%
ROIC N/A
ROA(3y)-79.21%
ROA(5y)-72.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of SNAX (18.66%) is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for SNAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

SNAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for SNAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -6.07, we must say that SNAX is in the distress zone and has some risk of bankruptcy.
SNAX's Altman-Z score of -6.07 is on the low side compared to the rest of the industry. SNAX is outperformed by 87.91% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that SNAX has dependencies on debt financing.
SNAX's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. SNAX is outperformed by 87.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF N/A
Altman-Z -6.07
ROIC/WACCN/A
WACC10.34%

2.3 Liquidity

A Current Ratio of 0.76 indicates that SNAX may have some problems paying its short term obligations.
The Current ratio of SNAX (0.76) is worse than 84.62% of its industry peers.
SNAX has a Quick Ratio of 0.76. This is a bad value and indicates that SNAX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.31, SNAX is doing worse than 93.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.31

5

3. Growth

3.1 Past

SNAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.21%, which is quite impressive.
Looking at the last year, SNAX shows a very negative growth in Revenue. The Revenue has decreased by -35.48% in the last year.
SNAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.62% yearly.
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q24.58%
Revenue 1Y (TTM)-35.48%
Revenue growth 3Y40.62%
Revenue growth 5YN/A
Revenue growth Q2Q-32.25%

3.2 Future

SNAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.29% yearly.
The Revenue is expected to grow by 12.00% on average over the next years. This is quite good.
EPS Next Y86.11%
EPS Next 2Y27.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-34.07%
Revenue Next 2Y12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

SNAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SNAX's earnings are expected to grow with 27.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.29%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SNAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STRYVE FOODS INC-CLASS A

NASDAQ:SNAX (5/2/2024, 7:19:56 PM)

1.465

-0.03 (-2.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.64M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.5%
ROE -317.88%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.76
Quick Ratio 0.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y86.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-35.48%
Revenue growth 3Y40.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y